Pooled analysis of prognostic impact of uPA and PAI-1 in breast cancer patients

Autor: Look M, van Putten W, Duffy M, Harbeck N, Ij, Christensen, Thomssen C, Kates R, Spyratos F, Fernö M, Eppenberger-Castori S, Cg, Fred Sweep, Ulm K, Jp, Peyrat, Pm, Martin, Magdelenat H, Brünner N, Catherine Duggan, Bw, Lisboa, Po, Bendahl, Quillien V, Daver A, Ricolleau G, Meijer-van Gelder M, Manders P, Edward Fiets W, Blankenstein M, Broët P, Romain S, Daxenbichler G, Windbichler G, Cufer T, Borstnar S, Kueng W, Beex L, Klijn J, O'Higgins N, Eppenberger U, Jänicke F, Schmitt M, Foekens J, Po, Bendah

Publikováno v: Thrombosis and Haemostasis, 90, 538-48
Thrombosis and Haemostasis, 90, 538-548. Georg Thieme Verlag
Europe PubMed Central
Thrombosis and Haemostasis, 90, 3, pp. 538-48
Scopus-Elsevier

Item does not contain fulltext In this report we present an extension of the pooled analysis of the prognostic impact of urokinase-type plasminogen activator (uPA) and its inhibitor PAI-I in breast cancer patients. We analyzed a different endpoint, m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78c930058ef1b9e1daab6d7e59894e29
https://doi.org/10.1160/th02-11-0264

Prediction of High Nodal Burden in Patients With Sentinel Node-Positive Luminal ERBB2-Negative Breast Cancer.

Autor: Skarping I; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden.; Department of Clinical Physiology and Nuclear Medicine, Skane University Hospital, Lund, Sweden., Bendahl PO; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Szulkin R; Cytel Inc, Sweden.; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Sweden., Alkner S; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden.; Department of Hematology, Oncology and Radiation Physics, Skane University Hospital, Lund, Sweden., Andersson Y; Department of Surgery, Västmanland Hospital, Västerås, Sweden.; Centre for Clinical Research Uppsala University, Västmanland Hospital Västerås, Sweden., Bergkvist L; Centre for Clinical Research Uppsala University, Västmanland Hospital Västerås, Sweden., Christiansen P; Department of Plastic and Breast Surgery, Aarhus University Hosoital, Denmark., Filtenborg Tvedskov T; Department of Breast Surgery, Gentofte Hospital, Denmark.; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Frisell J; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Breast Center Karolinska, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden., Gentilini OD; Università Vita-Salute San Raffaele, Milano, Italy.; IRCCS Ospedale San Raffaele, Milano, Italy., Kontos M; 1st Department of Surgery, National and Kapodistrian University of Athens, Laiko Hospital, Athens, Greece., Kühn T; Interdisciplinary Breast Center, University of Ulm, Ulm, Germany.; Breast Center Die Filderklinik, Filderstadt, Germany., Lundstedt D; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden., Vrou Offersen B; Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.; Aarhus University, Faculty of Health, Aarhus, Denmark., Olofsson Bagge R; Sahlgrenska Center for Cancer Research, Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden.; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden., Reimer T; Department of Obstetrics and Gynecology, University of Rostock, Rostock, Germany., Sund M; Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Department of Diagnostics and Intervention/Surgery, Umeå University, Umeå, Sweden., Rydén L; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden.; Department of Surgery and Gastroenterology, Skane University Hospital, Lund, Sweden., de Boniface J; Department of Surgery, Capio St Göran's Hospital, Stockholm, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Publikováno v: JAMA surgery [JAMA Surg] 2024 Sep 25. Date of Electronic Publication: 2024 Sep 25.

Health-related quality of life by type of breast surgery in women with primary breast cancer: prospective longitudinal cohort study.

Autor: Gulis K; Department of Surgery, Kristianstad Central Hospital, Kristianstad, Sweden.; Department of Clinical Sciences Lund, Division of Surgery, Lund University, Lund, Sweden., Ellbrant J; Department of Clinical Sciences Lund, Division of Surgery, Lund University, Lund, Sweden.; Department of Surgery, Skåne University Hospital, Malmö, Sweden., Bendahl PO; Department of Clinical Sciences Lund, Division of Oncology, Lund University, Lund, Sweden., Svensjö T; Department of Surgery, Kristianstad Central Hospital, Kristianstad, Sweden., Rydén L; Department of Clinical Sciences Lund, Division of Surgery, Lund University, Lund, Sweden.; Department of Surgery, Skåne University Hospital, Malmö, Sweden.

Publikováno v: BJS open [BJS Open] 2024 May 08; Vol. 8 (3).

Gene expression in metastatic breast cancer-patterns in primary tumors and metastatic tissue with prognostic potential.

Autor: Tutzauer J; Department of Clinical Sciences Lund, Division of Oncology, Lund University, Lund, Sweden., Larsson AM; Department of Clinical Sciences Lund, Division of Oncology, Lund University, Lund, Sweden., Aaltonen K; Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden., Bergenfelz C; Division of Experimental Infection Medicine, Department of Translational Medicine, Lund University, Malmö, Sweden., Bendahl PO; Department of Clinical Sciences Lund, Division of Oncology, Lund University, Lund, Sweden., Rydén L; Department of Clinical Sciences Lund, Division of Surgery, Lund University, Lund, Sweden.; Department of Surgery, Skåne University Hospital, Malmö, Sweden.

Publikováno v: Frontiers in molecular biosciences [Front Mol Biosci] 2024 Feb 21; Vol. 10, pp. 1343979. Date of Electronic Publication: 2024 Feb 21 (Print Publication: 2023).

Noninvasive Staging of Lymph Node Status in Breast Cancer Using Machine Learning: External Validation and Further Model Development.

Autor: Hjärtström M; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Dihge L; Division of Surgery, Department of Clinical Sciences, Lund University, Lund, Sweden.; Department of Plastic and Reconstructive Surgery, Skåne University Hospital, Malmö, Sweden., Bendahl PO; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Skarping I; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden.; Department of Clinical Physiology and Nuclear Medicine, Skåne University Hospital, Malmö, Sweden., Ellbrant J; Division of Surgery, Department of Clinical Sciences, Lund University, Lund, Sweden.; Department of Surgery, Skåne University Hospital, Malmö, Sweden., Ohlsson M; Department of Astronomy and Theoretical Physics, Lund University, Lund, Sweden.; Centre for Applied Intelligent Systems Research, Halmstad University, Halmstad, Sweden., Rydén L; Division of Surgery, Department of Clinical Sciences, Lund University, Lund, Sweden.; Department of Surgery and Gastroenterology, Skåne University Hospital, Malmö, Sweden.

Publikováno v: JMIR cancer [JMIR Cancer] 2023 Nov 20; Vol. 9, pp. e46474. Date of Electronic Publication: 2023 Nov 20.